Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases

Completed · Phase 2

Conditions studied: Bone Marrow Failure Syndromes, Immunodeficiencies, Immune Dysregulation Syndromes

In brief

This is a Phase II trial to determine the ability of a reduced intensity conditioning regimen to allow successful engraftment with CD3+ /CD19+ depleted peripheral stem cell grafts from mismatched donors. There are two conditioning regimens depending upon patient diagnosis and age.

Key facts

Study ID
NCT02277639
Run by
Children's Hospital of Philadelphia
People needed
2
Starts
2011-11-01
Expected to finish
2016-03-01
Last updated by the study team
2018-04-11

Who can join

Age: any, up to 22. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.